[
    [
        {
            "time": "2020-12-31",
            "original_text": "凯莱英2020年度净利同比增三成 拟10派6元",
            "features": {
                "keywords": [
                    "凯莱英",
                    "2020年度",
                    "净利",
                    "同比增三成",
                    "10派6元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "凯莱英2020年度净利同比增三成 拟10派6元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "凯莱英：2020年净利同比增30% 拟10派6元",
            "features": {
                "keywords": [
                    "凯莱英",
                    "2020年",
                    "净利",
                    "同比增30%",
                    "拟10派6元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "凯莱英：2020年净利同比增30% 拟10派6元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "凯莱英(002821.SZ)：2020年度净利升30.37%至7.22亿元 拟10派6元",
            "features": {
                "keywords": [
                    "凯莱英",
                    "2020年度",
                    "净利",
                    "升30.37%",
                    "7.22亿元",
                    "拟10派6元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "凯莱英(002821.SZ)：2020年度净利升30.37%至7.22亿元 拟10派6元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "凯莱英：2020年净利同比增长30% 高瓴资本4季度增持300.5万股股份",
            "features": {
                "keywords": [
                    "凯莱英",
                    "2020年",
                    "净利",
                    "同比增长30%",
                    "高瓴资本",
                    "增持",
                    "300.5万股"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "凯莱英：2020年净利同比增长30% 高瓴资本4季度增持300.5万股股份",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "凯莱英(002821.SZ)年度归母净利同比增30.37%至7.22亿元 每10股派6元",
            "features": {
                "keywords": [
                    "凯莱英",
                    "归母净利",
                    "同比增30.37%",
                    "7.22亿元",
                    "每10股派6元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "凯莱英(002821.SZ)年度归母净利同比增30.37%至7.22亿元 每10股派6元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "凯莱英：2020年净利润同比增长30.37%",
            "features": {
                "keywords": [
                    "凯莱英",
                    "2020年",
                    "净利润",
                    "同比增长30.37%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "凯莱英：2020年净利润同比增长30.37%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-12-31",
            "original_text": "高瓴资本概念股走势分化，国瓷材料、凯莱英、公牛集团、海正药业、健康元逆势上涨",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "走势分化",
                    "凯莱英",
                    "逆势上涨"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "消费",
                    "化工"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股走势分化，国瓷材料、凯莱英、公牛集团、海正药业、健康元逆势上涨",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]